Media Advisory
On March 9, Esther Latres, Ph.D., vice president of research at Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, will chair and present at “Cell Replacement Therapy,” a session at the Advanced Technologies &Treatments for Diabetes (ATTD) international conference in Florence, Italy.
Dr. Latres’ presentation will address cell therapies as one of the most promising ways to cure T1D and will set the stage for the progress being made in research and future opportunities for cell therapies.
Following Dr. Latres’ introduction, the following researchers will share their insights:
- Peter Senior: 20-year outcomes of islet cell transplantation – The benchmark for stem cells?
- Jose Oberholzer: Islet cell replacement therapy for type 1 diabetes
- Qizhi Tang: Engineering beta cells to enable immunosuppression-free replacement therapy for type 1 diabetes
The session will conclude with a round table discussion.
What: Breakthrough T1D Vice President of Research chairs and presents at ATTD session on cell replacement therapy
Who: Breakthrough T1D Vice President of Research, Dr. Esther Latres, Dr. Peter Senior, Dr. Jose Oberholzer, Dr. Qizhi Tang
When: Saturday, March 9, 2024, 11:30 a.m. – 1 p.m. CET
Where: Hall F, Fortezza da Basso, Viale Filippo Strozzi,1 50129 – Florence, Italy
